Phenazocine hydrobromide

This classification denotes an opioid analgesic and narcotic C22H27NO.BrH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C1749020IH, chemically known as 2'-hydroxy-5,9-dimethyl-2-phenethyl-6,7-benzomorphan, hbr, but more generally known as phenazocine hydrobromide, which bears US NIH Compound Identifier 14706. European Medicines Agency schedules Phenazocine hydrobromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03734MIG. Most nations, for tariff and trade purposes, schedule phenazocine hydrobromide under HS 29333999 and SITC 51574. As of Q4 2014, PHENAZOCINE HYDROBROMIDE remains US FDA's Preferred Term for this commodity. Phenazocine hydrobromide bears US NLM identifiers UMLS ID C0600121 and NCI Concept Code C96729. SMILES: C[C@H]1[C@H]2CC3CCC(CC3[C@@]1(CCN2CCC4CCCCC4)C)O.BR.